The main signaling pathways enriched by KEGG included gastric cancer, breast cancer, proteoglycans in cancer, EGFR tyrosine kinase inhibitor resistance, endocrine resistance, hepatocellular carcinoma, MAPK signaling pathway, and hepatitis B. Here, EGFR is linked to gastric cancer.